CN Stock MarketDetailed Quotes

002868 Lifecome Biochemistry

Watchlist
  • 12.28
  • +0.19+1.57%
Market Closed Aug 30 15:00 CST
1.91BMarket Cap-7279P/E (TTM)

Lifecome Biochemistry Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
41.90%326.43M
60.09%160.4M
53.71%507M
69.90%397.67M
59.46%230.04M
59.83%100.19M
-9.23%329.85M
-7.17%234.07M
-17.01%144.27M
-31.06%62.69M
Operating revenue
41.90%326.43M
60.09%160.4M
53.71%507M
69.90%397.67M
59.46%230.04M
59.83%100.19M
-9.23%329.85M
-7.17%234.07M
-17.01%144.27M
-31.06%62.69M
Other operating revenue
4.59%9.73M
----
-19.22%17.07M
----
10.27%9.3M
----
5.19%21.14M
----
3,531.60%8.44M
----
Total operating cost
63.12%413.56M
69.53%188.47M
62.27%676.87M
62.67%471.64M
47.98%253.53M
57.99%111.17M
12.00%417.12M
18.64%289.94M
4.70%171.33M
-13.83%70.36M
Operating cost
57.96%326.66M
68.50%147.31M
62.91%552.43M
71.33%399.09M
55.92%206.8M
58.79%87.42M
11.62%339.1M
19.21%232.94M
0.26%132.63M
-18.61%55.05M
Operating tax surcharges
85.64%3.65M
17.80%1.16M
14.49%4.4M
2.64%3M
10.44%1.96M
24.25%982.74K
29.45%3.84M
32.13%2.92M
23.44%1.78M
14.47%790.94K
Operating expense
17.05%8.11M
8.22%3.68M
47.26%15.93M
51.36%10.86M
46.16%6.93M
35.70%3.4M
-27.75%10.82M
-35.91%7.17M
-35.69%4.74M
-25.72%2.5M
Administration expense
109.44%25.15M
73.89%12.22M
39.46%38.13M
0.59%18.85M
-12.49%12.01M
63.39%7.03M
22.51%27.34M
34.82%18.74M
53.77%13.72M
0.04%4.3M
Financial expense
142.79%30.85M
141.84%16.27M
171.06%38.45M
107.36%20.23M
107.66%12.71M
249.16%6.73M
298.82%14.19M
443.87%9.75M
497.09%6.12M
405.94%1.93M
-Interest expense (Financial expense)
171.52%31.39M
330.52%15.55M
128.74%37.1M
75.51%14.4M
82.37%11.56M
202.30%3.61M
476.50%16.22M
491.58%8.21M
1,034.74%6.34M
1,276.82%1.19M
-Interest Income (Financial expense)
-147.99%-450.64K
-34.00%-153.41K
30.55%-123.3K
37.16%-228.15K
38.70%-181.71K
36.78%-114.48K
78.56%-177.54K
13.41%-363.04K
24.43%-296.42K
63.70%-181.09K
Research and development
45.85%19.15M
39.65%7.84M
26.14%27.53M
6.56%19.62M
6.43%13.13M
-3.02%5.61M
-12.07%21.82M
-7.42%18.41M
-1.94%12.33M
-7.88%5.79M
Credit Impairment Loss
118.05%148.57K
-426.18%-2.46M
-16.20%-1.66M
-45.32%-1.23M
-186.55%-823.23K
-157.54%-466.89K
-180.81%-1.43M
-43.54%-844.05K
52.67%-287.29K
262.22%811.42K
Asset Impairment Loss
-4.51%-48.06M
58.80%-9.86M
-64.84%-79.24M
-125.12%-32.41M
-277.82%-45.98M
-6,129.13%-23.93M
-520.59%-48.07M
-136.78%-14.4M
-210.79%-12.17M
78.05%-384.1K
Other net revenue
-40.13%-29.81M
-2,925.52%-11.49M
-42.52%-66.26M
56.28%-9.9M
-30.04%-21.27M
111.93%406.67K
-93.48%-46.49M
-53.17%-22.65M
-294.35%-16.36M
56.11%-3.41M
Invest income
-50.38%11.92M
-100.31%-62.96K
212.95%11.43M
284.34%21.61M
499.94%24.02M
519.07%20.61M
50.78%-10.12M
8.24%-11.72M
-148.54%-6.01M
32.20%-4.92M
-Including: Investment income associates
82.07%-381.44K
84.55%-62.96K
63.85%-3.82M
62.74%-4.53M
67.02%-2.13M
91.71%-407.52K
51.88%-10.56M
14.12%-12.17M
-69.07%-6.45M
32.20%-4.92M
Asset deal income
11,636.16%4.25M
----
---36.21K
---36.21K
--36.21K
----
----
----
----
----
Other revenue
30.81%1.93M
-78.85%885.87K
-75.25%3.25M
-50.10%2.15M
-29.89%1.48M
286.74%4.19M
174.87%13.13M
-7.38%4.31M
-24.52%2.11M
-37.78%1.08M
Operating profit
-161.25%-116.94M
-274.27%-39.56M
-76.53%-236.13M
-6.81%-83.87M
-3.10%-44.76M
4.62%-10.57M
-304.37%-133.76M
-1,018.03%-78.53M
-815.50%-43.42M
-834.28%-11.08M
Add:Non operating Income
217.34%190.18K
--0
79.59%431.05K
3,028.59%109.51K
1,881.29%59.93K
--71K
-76.22%240.02K
51.48%3.5K
30.90%3.02K
--0
Less:Non operating expense
-97.42%107.83K
439.58%56.34K
779.19%5.19M
4,162.95%4.28M
8,248.97%4.17M
-73.90%10.44K
110.36%590.61K
213.20%100.4K
64.91%50K
33.33%40K
Total profit
-139.09%-116.86M
-276.97%-39.62M
-79.62%-240.89M
-11.98%-88.04M
-12.45%-48.88M
5.51%-10.51M
-314.56%-134.11M
-1,014.68%-78.62M
-819.60%-43.46M
-851.72%-11.12M
Less:Income tax cost
-1,350.57%-29.14M
-8,567.36%-8.04M
-60.48%-18.28M
86.54%-1.42M
70.48%-2.01M
95.62%-92.82K
-92.83%-11.39M
-1,040.49%-10.53M
-1,427.04%-6.81M
-160.11%-2.12M
Net profit
FPtoL-87.71M
FPtoL-31.57M
FPtoL-222.62M
FPtoL-86.62M
FPtoL-46.87M
FPtoL-10.42M
FPtoL-122.72M
FPtoL-68.09M
SL-36.66M
SL-9M
Net profit from continuing operation
-87.15%-87.71M
-203.10%-31.57M
-81.40%-222.62M
-27.22%-86.62M
-27.85%-46.87M
-15.69%-10.42M
-364.08%-122.72M
-1,010.80%-68.09M
-665.22%-36.66M
-492.46%-9M
Less:Minority Profit
-213.89%-635.26K
15.13%-230.42K
-2.01%-799.22K
-71.90%-544.98K
-60.36%-202.38K
-201.15%-271.49K
-95.75%-783.44K
-99.88%-317.04K
-58.87%-126.2K
16.20%-90.15K
Net profit of parent company owners
-86.60%-87.08M
-208.94%-31.34M
-81.91%-221.82M
-27.01%-86.08M
-27.74%-46.67M
-13.82%-10.15M
-368.20%-121.94M
-1,034.99%-67.78M
-656.46%-36.53M
-471.12%-8.91M
Earning per share
Basic earning per share
-86.67%-0.56
-185.71%-0.2
-82.28%-1.44
-27.27%-0.56
-25.00%-0.3
-16.67%-0.07
-364.71%-0.79
-1,000.00%-0.44
-700.00%-0.24
-400.00%-0.06
Diluted earning per share
-86.67%-0.56
-185.71%-0.2
-82.28%-1.44
-27.27%-0.56
-25.00%-0.3
-16.67%-0.07
-364.71%-0.79
-1,000.00%-0.44
-700.00%-0.24
-400.00%-0.06
Other composite income
Total composite income
-87.15%-87.71M
-203.10%-31.57M
-81.40%-222.62M
-27.22%-86.62M
-27.85%-46.87M
-15.69%-10.42M
-364.07%-122.72M
-1,010.80%-68.09M
-665.21%-36.66M
-492.47%-9M
Total composite income of parent company owners
-86.60%-87.08M
-208.94%-31.34M
-81.91%-221.82M
-27.01%-86.08M
-27.74%-46.67M
-13.82%-10.15M
-368.19%-121.94M
-1,034.99%-67.78M
-656.45%-36.53M
-471.13%-8.91M
Total composite income of minority owners
-213.89%-635.26K
15.13%-230.42K
-2.01%-799.22K
-71.90%-544.98K
-60.36%-202.38K
-201.15%-271.49K
-95.75%-783.44K
-99.88%-317.04K
-58.87%-126.2K
16.20%-90.15K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 41.90%326.43M60.09%160.4M53.71%507M69.90%397.67M59.46%230.04M59.83%100.19M-9.23%329.85M-7.17%234.07M-17.01%144.27M-31.06%62.69M
Operating revenue 41.90%326.43M60.09%160.4M53.71%507M69.90%397.67M59.46%230.04M59.83%100.19M-9.23%329.85M-7.17%234.07M-17.01%144.27M-31.06%62.69M
Other operating revenue 4.59%9.73M-----19.22%17.07M----10.27%9.3M----5.19%21.14M----3,531.60%8.44M----
Total operating cost 63.12%413.56M69.53%188.47M62.27%676.87M62.67%471.64M47.98%253.53M57.99%111.17M12.00%417.12M18.64%289.94M4.70%171.33M-13.83%70.36M
Operating cost 57.96%326.66M68.50%147.31M62.91%552.43M71.33%399.09M55.92%206.8M58.79%87.42M11.62%339.1M19.21%232.94M0.26%132.63M-18.61%55.05M
Operating tax surcharges 85.64%3.65M17.80%1.16M14.49%4.4M2.64%3M10.44%1.96M24.25%982.74K29.45%3.84M32.13%2.92M23.44%1.78M14.47%790.94K
Operating expense 17.05%8.11M8.22%3.68M47.26%15.93M51.36%10.86M46.16%6.93M35.70%3.4M-27.75%10.82M-35.91%7.17M-35.69%4.74M-25.72%2.5M
Administration expense 109.44%25.15M73.89%12.22M39.46%38.13M0.59%18.85M-12.49%12.01M63.39%7.03M22.51%27.34M34.82%18.74M53.77%13.72M0.04%4.3M
Financial expense 142.79%30.85M141.84%16.27M171.06%38.45M107.36%20.23M107.66%12.71M249.16%6.73M298.82%14.19M443.87%9.75M497.09%6.12M405.94%1.93M
-Interest expense (Financial expense) 171.52%31.39M330.52%15.55M128.74%37.1M75.51%14.4M82.37%11.56M202.30%3.61M476.50%16.22M491.58%8.21M1,034.74%6.34M1,276.82%1.19M
-Interest Income (Financial expense) -147.99%-450.64K-34.00%-153.41K30.55%-123.3K37.16%-228.15K38.70%-181.71K36.78%-114.48K78.56%-177.54K13.41%-363.04K24.43%-296.42K63.70%-181.09K
Research and development 45.85%19.15M39.65%7.84M26.14%27.53M6.56%19.62M6.43%13.13M-3.02%5.61M-12.07%21.82M-7.42%18.41M-1.94%12.33M-7.88%5.79M
Credit Impairment Loss 118.05%148.57K-426.18%-2.46M-16.20%-1.66M-45.32%-1.23M-186.55%-823.23K-157.54%-466.89K-180.81%-1.43M-43.54%-844.05K52.67%-287.29K262.22%811.42K
Asset Impairment Loss -4.51%-48.06M58.80%-9.86M-64.84%-79.24M-125.12%-32.41M-277.82%-45.98M-6,129.13%-23.93M-520.59%-48.07M-136.78%-14.4M-210.79%-12.17M78.05%-384.1K
Other net revenue -40.13%-29.81M-2,925.52%-11.49M-42.52%-66.26M56.28%-9.9M-30.04%-21.27M111.93%406.67K-93.48%-46.49M-53.17%-22.65M-294.35%-16.36M56.11%-3.41M
Invest income -50.38%11.92M-100.31%-62.96K212.95%11.43M284.34%21.61M499.94%24.02M519.07%20.61M50.78%-10.12M8.24%-11.72M-148.54%-6.01M32.20%-4.92M
-Including: Investment income associates 82.07%-381.44K84.55%-62.96K63.85%-3.82M62.74%-4.53M67.02%-2.13M91.71%-407.52K51.88%-10.56M14.12%-12.17M-69.07%-6.45M32.20%-4.92M
Asset deal income 11,636.16%4.25M-------36.21K---36.21K--36.21K--------------------
Other revenue 30.81%1.93M-78.85%885.87K-75.25%3.25M-50.10%2.15M-29.89%1.48M286.74%4.19M174.87%13.13M-7.38%4.31M-24.52%2.11M-37.78%1.08M
Operating profit -161.25%-116.94M-274.27%-39.56M-76.53%-236.13M-6.81%-83.87M-3.10%-44.76M4.62%-10.57M-304.37%-133.76M-1,018.03%-78.53M-815.50%-43.42M-834.28%-11.08M
Add:Non operating Income 217.34%190.18K--079.59%431.05K3,028.59%109.51K1,881.29%59.93K--71K-76.22%240.02K51.48%3.5K30.90%3.02K--0
Less:Non operating expense -97.42%107.83K439.58%56.34K779.19%5.19M4,162.95%4.28M8,248.97%4.17M-73.90%10.44K110.36%590.61K213.20%100.4K64.91%50K33.33%40K
Total profit -139.09%-116.86M-276.97%-39.62M-79.62%-240.89M-11.98%-88.04M-12.45%-48.88M5.51%-10.51M-314.56%-134.11M-1,014.68%-78.62M-819.60%-43.46M-851.72%-11.12M
Less:Income tax cost -1,350.57%-29.14M-8,567.36%-8.04M-60.48%-18.28M86.54%-1.42M70.48%-2.01M95.62%-92.82K-92.83%-11.39M-1,040.49%-10.53M-1,427.04%-6.81M-160.11%-2.12M
Net profit FPtoL-87.71MFPtoL-31.57MFPtoL-222.62MFPtoL-86.62MFPtoL-46.87MFPtoL-10.42MFPtoL-122.72MFPtoL-68.09MSL-36.66MSL-9M
Net profit from continuing operation -87.15%-87.71M-203.10%-31.57M-81.40%-222.62M-27.22%-86.62M-27.85%-46.87M-15.69%-10.42M-364.08%-122.72M-1,010.80%-68.09M-665.22%-36.66M-492.46%-9M
Less:Minority Profit -213.89%-635.26K15.13%-230.42K-2.01%-799.22K-71.90%-544.98K-60.36%-202.38K-201.15%-271.49K-95.75%-783.44K-99.88%-317.04K-58.87%-126.2K16.20%-90.15K
Net profit of parent company owners -86.60%-87.08M-208.94%-31.34M-81.91%-221.82M-27.01%-86.08M-27.74%-46.67M-13.82%-10.15M-368.20%-121.94M-1,034.99%-67.78M-656.46%-36.53M-471.12%-8.91M
Earning per share
Basic earning per share -86.67%-0.56-185.71%-0.2-82.28%-1.44-27.27%-0.56-25.00%-0.3-16.67%-0.07-364.71%-0.79-1,000.00%-0.44-700.00%-0.24-400.00%-0.06
Diluted earning per share -86.67%-0.56-185.71%-0.2-82.28%-1.44-27.27%-0.56-25.00%-0.3-16.67%-0.07-364.71%-0.79-1,000.00%-0.44-700.00%-0.24-400.00%-0.06
Other composite income
Total composite income -87.15%-87.71M-203.10%-31.57M-81.40%-222.62M-27.22%-86.62M-27.85%-46.87M-15.69%-10.42M-364.07%-122.72M-1,010.80%-68.09M-665.21%-36.66M-492.47%-9M
Total composite income of parent company owners -86.60%-87.08M-208.94%-31.34M-81.91%-221.82M-27.01%-86.08M-27.74%-46.67M-13.82%-10.15M-368.19%-121.94M-1,034.99%-67.78M-656.45%-36.53M-471.13%-8.91M
Total composite income of minority owners -213.89%-635.26K15.13%-230.42K-2.01%-799.22K-71.90%-544.98K-60.36%-202.38K-201.15%-271.49K-95.75%-783.44K-99.88%-317.04K-58.87%-126.2K16.20%-90.15K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg